Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Addex And Perceptive Launch Neurosterix With $63M To Accelerate Development Of Allosteric Modulator Therapeutics For Neurological Disorders

Author: Benzinga Newsdesk | April 03, 2024 01:36am

Addex receives CHF5M and 20% share of Neurosterix
Perceptive Advisors leads $63M investment into Neurosterix
Addex contributes portfolio of preclinical neuroscience assets and allosteric modulator small molecule discovery technology platform to Neurosterix

Posted In: ADXN